BriaCell director, president, CEO Wagner resigns
BriaCell Therapeutics Corp (C:BCT)
Shares Issued 84,736,315
Last Close 3/24/2016 $0.14
Thursday March 24 2016 - News Release
Dr. Saeid Babaei reports
BRIACELL ANNOUNCES SENIOR MANAGEMENT CHANGE
Dr. Joseph Wagner has resigned his positions as president and chief executive officer of BriaCell Therapeutics Corp., effective immediately, to pursue other opportunities. Dr. Wagner has also stepped down from the board. Rahoul Sharan, director of the company, has been appointed chief executive officer on an interim basis as the board searches for a suitable long-term replacement. Mr. Sharan brings 25 years of corporate finance experience, in which he has led financings in excess of several hundred million dollars. Dr. Wagner has committed to supporting BriaCell on a consulting basis to facilitate a smooth transition over the next few months.
Dr. Wagner commented: "While CEO of BriaCell, the company obtained FDA [Food and Drug Administration] approval to launch its phase IIa clinical trial, and partnered with UC Davis in manufacturing cGMP [current good manufacturing practice]-grade material for the planned trial. As the company finally readies for its clinical trial, I am confident that current management and active directors have the necessary expertise to oversee the launch, and I will do my best to support these activities."
Dr. Saeid Babaei, chairman of the board, commented: "We thank Dr. Wagner for his contribution over the last year in advancing the manufacturing of BriaVax, as well as to establish the company's research laboratory in [the] East Bay innovation corridor in Berkeley, Calif. On behalf of my colleagues, I wish him the very best in his future endeavours. The next phase of BriaCell's growth is a very exciting one, and we are looking to share our progress with our partners and investors."
© 2016 Canjex Publishing Ltd.
This email was sent to you at mick27murphy@gmail.com by Stockwatch ( www.stockwatch.com) as part of your package of Stockwatch services, and in accordance with your ema |
